Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helio S Sader

Showing results (31-40 of 420) with videos related to

Pageof 42
Sort By:
Diagnostic Microbiology and Infectious Disease|February 9, 2005
Antimicrobial activity of LBM415 (NVP PDF-713) tested against pathogenic Neisseria spp. (Neisseria gonorrhoeae and Neisseria meningitidis)Ronald N Jones, Helio S Sader, Thomas R Fritsche
Diagnostic Microbiology and Infectious Disease|June 9, 2004
Doxycycline use for community-acquired pneumonia: contemporary in vitro spectrum of activity against Streptococcus pneumoniae (1999-2002)Ronald N Jones, Helio S Sader, Thomas R Fritsche
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 22, 2008
Antimicrobial activity of daptomycin and selected comparators tested against bloodstream Staphylococcus aureus isolates from hemodialysis patientsHelio S Sader, Thomas R Fritsche, Ronald N Jones
Antimicrobial Agents and Chemotherapy|March 18, 2009
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolatesHelio S Sader, Thomas R Fritsche, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|October 3, 2003
Comparative activity and spectrum of broad-spectrum beta-lactams (cefepime, ceftazidime, ceftriaxone, piperacillin/tazobactam) tested against 12,295 staphylococci and streptococci: report from the SENTRY antimicrobial surveillance program (North America: 2001-2002)Thomas R Fritsche, Helio S Sader, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|September 12, 2003
Global patterns of susceptibility for 21 commonly utilized antimicrobial agents tested against 48,440 Enterobacteriaceae in the SENTRY Antimicrobial Surveillance Program (1997-2001)Helio S Sader, Douglas J Biedenbach, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|December 21, 2002
Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program (1997-2000)Ana C Gales, Helio S Sader, Ronald N Jones, et al.
Diagnostic Microbiology and Infectious Disease|January 30, 2013
Update of dalbavancin spectrum and potency in the USA: report from the SENTRY Antimicrobial Surveillance Program (2011)Ronald N Jones, Helio S Sader, Robert K Flamm
Journal of Chemotherapy (Florence, Italy)|October 5, 2013
Frequency of occurrence and antimicrobial susceptibility of Gram-negative bacteremia isolates in patients with urinary tract infection: results from United States and European hospitals (2009-2011)Helio S Sader, Robert K Flamm, Ronald N Jones
Journal of Clinical Microbiology|March 7, 2006
Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum beta-lactam agentsHelio S Sader, Thomas R Fritsche, Ronald N Jones
Pageof 42

Showing results (31-40 of 420) with videos related to

Sort By:
Pageof 42
Diagnostic Microbiology and Infectious Disease|February 9, 2005
Antimicrobial activity of LBM415 (NVP PDF-713) tested against pathogenic Neisseria spp. (Neisseria gonorrhoeae and Neisseria meningitidis)Ronald N Jones, Helio S Sader, Thomas R Fritsche
Diagnostic Microbiology and Infectious Disease|June 9, 2004
Doxycycline use for community-acquired pneumonia: contemporary in vitro spectrum of activity against Streptococcus pneumoniae (1999-2002)Ronald N Jones, Helio S Sader, Thomas R Fritsche
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 22, 2008
Antimicrobial activity of daptomycin and selected comparators tested against bloodstream Staphylococcus aureus isolates from hemodialysis patientsHelio S Sader, Thomas R Fritsche, Ronald N Jones
Antimicrobial Agents and Chemotherapy|March 18, 2009
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolatesHelio S Sader, Thomas R Fritsche, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|October 3, 2003
Comparative activity and spectrum of broad-spectrum beta-lactams (cefepime, ceftazidime, ceftriaxone, piperacillin/tazobactam) tested against 12,295 staphylococci and streptococci: report from the SENTRY antimicrobial surveillance program (North America: 2001-2002)Thomas R Fritsche, Helio S Sader, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|September 12, 2003
Global patterns of susceptibility for 21 commonly utilized antimicrobial agents tested against 48,440 Enterobacteriaceae in the SENTRY Antimicrobial Surveillance Program (1997-2001)Helio S Sader, Douglas J Biedenbach, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|December 21, 2002
Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program (1997-2000)Ana C Gales, Helio S Sader, Ronald N Jones, et al.
Diagnostic Microbiology and Infectious Disease|January 30, 2013
Update of dalbavancin spectrum and potency in the USA: report from the SENTRY Antimicrobial Surveillance Program (2011)Ronald N Jones, Helio S Sader, Robert K Flamm
Journal of Chemotherapy (Florence, Italy)|October 5, 2013
Frequency of occurrence and antimicrobial susceptibility of Gram-negative bacteremia isolates in patients with urinary tract infection: results from United States and European hospitals (2009-2011)Helio S Sader, Robert K Flamm, Ronald N Jones
Journal of Clinical Microbiology|March 7, 2006
Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum beta-lactam agentsHelio S Sader, Thomas R Fritsche, Ronald N Jones
Pageof 42